Dan Lebowitz
Impact in
-
- Diabetic Foot Ulcer Assessment and Management
-
- Antibiotic Use and Resistance
Papers in
-
- Diabetic Foot Ulcer Assessment and Management 9
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 3
- Infection Control in Healthcare 2
- Co-authors
- Karim Gariani (9 shared papers)İlker Uçkay (10 shared papers)Benjamin Kressmann (8 shared papers)Benjamin Alan Lipsky (7 shared papers)Elodie von Dach (4 shared papers)Pierre Parneix (1 shared paper)Alexandra Peters (1 shared paper)Walter Zingg (1 shared paper)
- Journals
- Scandinavian Journal of Infectious Diseases (3 papers)International Journal of Infectious Diseases (2 papers)BMJ Open (2 papers)Diabetes Obesity and Metabolism (2 papers)EClinicalMedicine (1 paper)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Dan Lebowitz
25 papers receiving 366 citations
Peers
Comparison fields: 5 of 55
- Endocrinology, Diabetes and Metabolism 153
- Applied Microbiology and Biotechnology 20
- Infectious Diseases 93
- Microbiology 4
- Drug Discovery 1
Countries citing papers authored by Dan Lebowitz
This map shows the geographic impact of Dan Lebowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lebowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lebowitz more than expected).
Fields of papers citing papers by Dan Lebowitz
This network shows the impact of papers produced by Dan Lebowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lebowitz. The network helps show where Dan Lebowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Lebowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 70 | |
| 2 | 2018 | 48 | |
| 3 | 2017 | 40 | |
| 4 | 2019 | 36 | |
| 5 | 2019 | 30 | |
| 6 | 2023 | 22 | |
| 7 | 2018 | 20 | |
| 8 | 2016 | 18 | |
| 9 | 2017 | 13 | |
| 10 | 2013 | 9 | |
| 11 | 2015 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2022 | 7 | |
| 14 | 2017 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2016 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2016 | 4 | |
| 20 | 2020 | 4 |
About Dan Lebowitz
Dan Lebowitz is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases, Surgery, Microbiology and Internal Medicine, having authored 27 papers that have together received 375 indexed citations. Recurring topics across this work include Diabetic Foot Ulcer Assessment and Management (9 papers), SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (3 papers), Orthopedic Infections and Treatments (2 papers), Pericarditis and Cardiac Tamponade (2 papers), Infection Control in Healthcare (2 papers), Streptococcal Infections and Treatments (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (153 citations), Applied Microbiology and Biotechnology (20 citations), Infectious Diseases (93 citations), Microbiology (4 citations) and Drug Discovery (1 citation). Dan Lebowitz has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Karim Gariani, İlker Uçkay, Benjamin Kressmann, Benjamin Alan Lipsky, Elodie von Dach, Pierre Parneix, Alexandra Peters, Walter Zingg, Marlieke E.A. de Kraker and Didier Pittet. Their work appears in journals such as Scandinavian Journal of Infectious Diseases, International Journal of Infectious Diseases, BMJ Open, Diabetes Obesity and Metabolism and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.